Triple Combination Antiviral Therapy

Kaur Simaranjit; Kaur Kuldeep; Kaur Herbaksh

Research Journal of Pharmacy and Technology

ISSN

0974-360X (Online)
0974-3618 (Print)

Submit Article

Triple Combination Antiviral Therapy

Author(s): Kaur Simaranjit, Kaur Kuldeep, Kaur Herbaksh

Email(s): onlyharsh24@gmail.com

DOI: Not Available

Address: Kaur Simaranjit, Kaur Kuldeep, Kaur Herbaksh
Assistant Professor, M.M College of Nursing, Mullana Ambala, Haryana
*Corresponding Author

Published In: Volume - 7, Issue - 10, Year - 2014

View HTML

View PDF

ABSTRACT:
Combination antiviral therapy helps to prevent the virus that causes hepatitis C from reproducing in the body along with HIV. Peg interferon and Ribavirin are combined to give the best response to treatment in case of HIV Positive. A protease inhibitor (such as Boceprevir or telaprevir) also may be given along with peg interferon and Ribavirin. Combination antiviral therapy is prescribed for those who have ongoing (chronic) hepatitis C infection. This therapy has certain side-effects that comes with medicine. Usually the benefits of the medicine are more important than any minor side effects i. e Fatigue, headache, muscle and joint aches etc. Periodic liver function tests and a liver biopsy every 3 to 5 years come in the special considerations. Follow-up care is a key part of treatment and safety. One has to be sure to make and go to all appointments, and call the doctor if there is any problem.

Keywords:

Combination Antiviral Therapy.

Cite this article:
Kaur Simaranjit, Kaur Kuldeep, Kaur Herbaksh. Triple Combination Antiviral Therapy. Research J. Pharm. and Tech. 7(10): Oct. 2014 Page 1190-1192.

Cite(Electronic):
Kaur Simaranjit, Kaur Kuldeep, Kaur Herbaksh. Triple Combination Antiviral Therapy. Research J. Pharm. and Tech. 7(10): Oct. 2014 Page 1190-1192. Available on: https://rjptonline.org/AbstractView.aspx?PID=2014-7-10-10